AtriCure, Inc. Finance Lease, Right-of-Use Asset, Amortization
AtriCure, Inc. (ATRC) reported Finance Lease, Right-of-Use Asset, Amortization of $261.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-07-27
- AtriCure, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $261.00K, a 0.38% decline year-over-year.
- AtriCure, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $262.00K, a 0.00% change year-over-year.
- AtriCure, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $261.00K, a 0.38% decline year-over-year.
- AtriCure, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $262.00K, a 0.00% change year-over-year.
- AtriCure, Inc. finance lease, right-of-use asset, amortization for fiscal 2025 was $1.05M, a 0.00% change from fiscal 2024.
- AtriCure, Inc. finance lease, right-of-use asset, amortization for fiscal 2024 was $1.05M, a 2.65% increase from fiscal 2023.
- AtriCure, Inc. finance lease, right-of-use asset, amortization for fiscal 2023 was $1.02M, a 0.39% increase from fiscal 2022.
- AtriCure, Inc. finance lease, right-of-use asset, amortization for fiscal 2022 was $1.02M, a 0.29% decline from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $261.00K 10-Q · filed 2026-07-27 | $523.00K 10-Q · filed 2026-07-27 | $784.00K derived: sum of 3 quarters · filed 2026-07-27 | $1.05M derived: sum of 4 quarters · filed 2026-07-27 |
| 2026-03-31 | $262.00K 10-Q · filed 2026-05-06 | $523.00K derived: sum of 2 quarters · filed 2026-05-06 | $785.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.05M derived: sum of 4 quarters · filed 2026-07-27 |
| 2025-12-31 | $261.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $523.00K derived: sum of 2 quarters · filed 2026-02-19 | $785.00K derived: sum of 3 quarters · filed 2026-07-27 | $1.05M 10-K · filed 2026-02-19 |
| 2025-09-30 | $262.00K 10-Q · filed 2025-10-30 | $524.00K derived: sum of 2 quarters · filed 2026-07-27 | $786.00K 10-Q · filed 2025-10-30 | $1.05M derived: sum of 4 quarters · filed 2026-07-27 |
| 2025-06-30 | $262.00K 10-Q · filed 2026-07-27 | $524.00K 10-Q · filed 2026-07-27 | $786.00K derived: sum of 3 quarters · filed 2026-07-27 | $1.05M derived: sum of 4 quarters · filed 2026-07-27 |
| 2025-03-31 | $262.00K 10-Q · filed 2026-05-06 | $524.00K derived: sum of 2 quarters · filed 2026-05-06 | $786.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.05M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $262.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $524.00K derived: sum of 2 quarters · filed 2026-02-19 | $792.00K derived: sum of 3 quarters · filed 2026-02-19 | $1.05M 10-K · filed 2026-02-19 |
| 2024-09-30 | $262.00K 10-Q · filed 2025-10-30 | $530.00K derived: sum of 2 quarters · filed 2025-10-30 | $785.00K 10-Q · filed 2025-10-30 | $1.04M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $268.00K 10-Q · filed 2025-07-30 | $523.00K 10-Q · filed 2025-07-30 | $778.00K derived: sum of 3 quarters · filed 2026-02-19 | $1.03M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $255.00K 10-Q · filed 2025-04-30 | $510.00K derived: sum of 2 quarters · filed 2026-02-19 | $765.00K derived: sum of 3 quarters · filed 2026-02-19 | $1.02M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $510.00K derived: sum of 2 quarters · filed 2026-02-19 | $765.00K derived: sum of 3 quarters · filed 2026-02-19 | $1.02M 10-K · filed 2026-02-19 |
| 2023-09-30 | $255.00K 10-Q · filed 2024-10-30 | $510.00K derived: sum of 2 quarters · filed 2024-10-30 | $765.00K 10-Q · filed 2024-10-30 | $1.02M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $255.00K 10-Q · filed 2024-07-31 | $510.00K 10-Q · filed 2024-07-31 | $765.00K derived: sum of 3 quarters · filed 2025-02-14 | $1.02M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $255.00K 10-Q · filed 2024-05-02 | $510.00K derived: sum of 2 quarters · filed 2025-02-14 | $763.00K derived: sum of 3 quarters · filed 2025-02-14 | $1.10M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $508.00K derived: sum of 2 quarters · filed 2025-02-14 | $846.00K derived: sum of 3 quarters · filed 2025-02-14 | $1.02M 10-K · filed 2025-02-14 |
| 2022-09-30 | $253.00K 10-Q · filed 2023-11-02 | $591.00K derived: sum of 2 quarters · filed 2023-11-02 | $761.00K 10-Q · filed 2023-11-02 | $1.01M derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-06-30 | $338.00K 10-Q · filed 2023-07-26 | $508.00K 10-Q · filed 2023-07-26 | $761.00K derived: sum of 3 quarters · filed 2024-02-16 | $1.03M derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-03-31 | $169.00K 10-Q · filed 2023-05-03 | $423.00K derived: sum of 2 quarters · filed 2024-02-16 | $690.00K derived: sum of 3 quarters · filed 2024-02-16 | $932.00K derived: sum of 4 quarters · filed 2024-02-16 |
| 2021-12-31 | $254.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $521.00K derived: sum of 2 quarters · filed 2024-02-16 | $763.00K derived: sum of 3 quarters · filed 2024-02-16 | $1.02M 10-K · filed 2024-02-16 |
| 2021-09-30 | $267.00K 10-Q · filed 2022-11-02 | $509.00K derived: sum of 2 quarters · filed 2022-11-02 | $765.00K 10-Q · filed 2022-11-02 | $1.03M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $242.00K 10-Q · filed 2022-08-03 | $484.00K 10-Q · filed 2022-08-03 | $762.00K derived: sum of 3 quarters · filed 2023-02-22 | $1.02M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $256.00K 10-Q · filed 2022-05-04 | $520.00K derived: sum of 2 quarters · filed 2023-02-22 | $780.00K derived: sum of 3 quarters · filed 2023-02-22 | $1.04M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $264.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $524.00K derived: sum of 2 quarters · filed 2023-02-22 | $787.00K derived: sum of 3 quarters · filed 2023-02-22 | $1.05M 10-K · filed 2023-02-22 |
| 2020-09-30 | $260.00K 10-Q · filed 2021-11-04 | $523.00K derived: sum of 2 quarters · filed 2021-11-04 | $786.00K 10-Q · filed 2021-11-04 | $1.04M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | $263.00K 10-Q · filed 2021-08-05 | $526.00K 10-Q · filed 2021-08-05 | $777.00K derived: sum of 3 quarters · filed 2022-02-17 | $1.02M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | $263.00K 10-Q · filed 2021-04-28 | $514.00K derived: sum of 2 quarters · filed 2022-02-17 | $761.00K derived: sum of 3 quarters · filed 2022-02-17 | $1.01M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $498.00K derived: sum of 2 quarters · filed 2022-02-17 | $748.00K derived: sum of 3 quarters · filed 2022-02-17 | $998.00K 10-K · filed 2022-02-17 |
| 2019-09-30 | $247.00K 10-Q · filed 2020-11-06 | $497.00K derived: sum of 2 quarters · filed 2020-11-06 | $747.00K 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $250.00K 10-Q · filed 2020-07-29 | $500.00K 10-Q · filed 2020-07-29 | ||
| 2019-03-31 | $250.00K 10-Q · filed 2020-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |